(Q40351569)

English

Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach

scientific article published on December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

thyroid carcinoma

1 reference

based on heuristic

2

object named as

Hitoshi Tsuda

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Osamu Matsubara

6

object named as

Osamu Matsubara

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Tetsuya Murakawa

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Takao Tanimoto

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Tetsuya Tanabe

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Satoshi Kitahara

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

1 reference

based on heuristic

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Pathology International

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

757-765

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Epidermal growth factor receptor and c-erbB-2 oncoprotein expression in female genital tract carcinosarcomas (malignant mixed müllerian tumors). Clinicopathologic study of 82 cases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

EGF-receptors in human normal and pathological thyroid tissue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Expression of erbB receptors mRNA in thyroid tissues.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Expression of HER2 and C-KIT in Nasopharyngeal Carcinoma: Implications for a New Therapeutic Approach

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Effect of dimerization on signal transduction and biological function of oncogenic Ros, insulin, and insulin-like growth factor I receptors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Molecular mechanisms of the effects of low concentrations of taxol in anaplastic thyroid cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

The EGFR as a target for anticancer therapy--focus on cetuximab

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Validation of tissue array technology in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Targeting epidermal growth factor receptor in head and neck cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

New cytotoxic and molecular-targeted therapies of head and neck tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Rationale and clinical validation of epidermal growth factor receptor as a target in the treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01902.X

21 January 2018

Identifiers

10.1111/J.1440-1827.2005.01902.X

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40351569&oldid=1895981982"